About 3 results found for searched term "M-1121" (0.181 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1629 | Ramucirumab | VEGFR/PDGFR |
| LY3009806; IMC-1121B | ||
| Ramucirumab is a direct VEGFR2 antagonist, that binds with high affinity to the extracellular domain of VEGFR2 and block the binding of natural VEGFR ligands (VEGF-A, VEGF-C and VEGF-D). | ||
| M21172 | M-1121 | Epigenetic Reader Domain |
| M‑1121 is a covalent and orally active inhibitor of the menin-MLL interaction capable of achieving complete and persistent tumor regression. | ||
| M9700 | ML213 | Potassium Channel |
| CID-3111211 | ||
| ML213 (CID-3111211) is a selective KV7.2 (KCNQ2) and KV7.4 (KCNQ4) channel opener, with EC50 values of 230 and 510 nM for KV7.2 and KV7.4, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
